Tripeptide analogues of MG132 as protease inhibitors

dc.contributor.authorPehere, A.D.
dc.contributor.authorNguyen, S.
dc.contributor.authorGarlick, S.K.
dc.contributor.authorWilson, D.W.
dc.contributor.authorHudson, I.
dc.contributor.authorSykes, M.J.
dc.contributor.authorMorton, J.D.
dc.contributor.authorAbell, A.D.
dc.date.issued2019
dc.description.abstractThe 26S proteasome and calpain are linked to a number of important human diseases. Here, we report a series of analogues of the prototypical tripeptide aldehyde inhibitor MG132 that show a unique combination of high activity and selectivity for calpains over proteasome. Tripeptide aldehydes (1-3) with an aromatic P3 substituent show enhanced activity and selectivity against ovine calpain 2 relative to chymotrypsin-like activity of proteasome. Docking studies reveal the key contacts between inhibitors and calpain to confirm the importance of the S3 pocket with respect to selectivity between calpains 1 and 2 and the proteasome.
dc.description.statementofresponsibilityAshok D. Pehere, Steven Nguyen, Sarah K. Garlick, Danny W. Wilson, Irene Hudson, Matthew J. Sykes, James D. Morton, Andrew D. Abell
dc.identifier.citationBioorganic and Medicinal Chemistry, 2019; 27(2):436-441
dc.identifier.doi10.1016/j.bmc.2018.12.022
dc.identifier.issn0968-0896
dc.identifier.issn1464-3391
dc.identifier.orcidWilson, D.W. [0000-0002-5073-1405]
dc.identifier.orcidAbell, A.D. [0000-0002-0604-2629]
dc.identifier.urihttp://hdl.handle.net/2440/118429
dc.language.isoen
dc.publisherElsevier
dc.relation.grantARC
dc.rights© 2018 Elsevier Ltd. All rights reserved.
dc.source.urihttps://doi.org/10.1016/j.bmc.2018.12.022
dc.subjectCalpain inhibitors; 26S proteasome inhibitors; peptidomimetics; medicinal chemistry
dc.titleTripeptide analogues of MG132 as protease inhibitors
dc.typeJournal article
pubs.publication-statusPublished

Files